Biomark Diagnostics BMKDF Stock
Biomark Diagnostics Price Chart
Biomark Diagnostics BMKDF Financial and Trading Overview
| Biomark Diagnostics stock price | 0.39 USD |
| Previous Close | 0.4 USD |
| Open | 0.4 USD |
| Bid | 0.37 USD x 500000 |
| Ask | 0.39 USD x 1500000 |
| Day's Range | 0.4 - 0.4 USD |
| 52 Week Range | 0.2 - 0.5 USD |
| Volume | 200 USD |
| Avg. Volume | 1.16K USD |
| Market Cap | 41.8M USD |
| Beta (5Y Monthly) | -0.25 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.01 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
BMKDF Valuation Measures
| Enterprise Value | 41.23M USD |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 455.53485 |
| Price/Book (mrq) | 111.02583 |
| Enterprise Value/Revenue | 449.276 |
| Enterprise Value/EBITDA | -21.112 |
Trading Information
Biomark Diagnostics Stock Price History
| Beta (5Y Monthly) | -0.25 |
| 52-Week Change | 72.95% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 0.5 USD |
| 52 Week Low | 0.2 USD |
| 50-Day Moving Average | 0.42 USD |
| 200-Day Moving Average | 0.35 USD |
BMKDF Share Statistics
| Avg. Volume (3 month) | 1.16K USD |
| Avg. Daily Volume (10-Days) | 961 USD |
| Shares Outstanding | 105.09M |
| Float | 48.05M |
| Short Ratio | N/A |
| % Held by Insiders | 48.38% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | March 31, 2025 |
| Most Recent Quarter (mrq) | December 31, 2025 |
| Next Fiscal Year End | March 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -7511.58% |
| Gross Margin | 100.00% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -81.69% |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 91.77K USD |
| Revenue Per Share (ttm) | 0.001 USD |
| Quarterly Revenue Growth (yoy) | -82.099% |
| Gross Profit (ttm) | 91.77K USD |
| EBITDA | -1952960 USD |
| Net Income Avi to Common (ttm) | -1699655 USD |
| Diluted EPS (ttm) | -0.01 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 1.29M USD |
| Total Cash Per Share (mrq) | 0.01 USD |
| Total Debt (mrq) | 711.78K USD |
| Total Debt/Equity (mrq) | 140.11 USD |
| Current Ratio (mrq) | 1.197 |
| Book Value Per Share (mrq) | 0.00358295 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -1421050 USD |
| Levered Free Cash Flow (ttm) | -949856 USD |
Profile of Biomark Diagnostics
| Country | United States |
| State | BC |
| City | Richmond |
| Address | 3851 Shell Road |
| ZIP | V6X 2W2 |
| Phone | 604 370 0779 |
| Website | https://www.biomarkdiagnostics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Biomark Diagnostics Inc. develops early-stage cancer diagnostic technology platform to detect and treat cancer. The company invests in and develops a liquid biopsy metabolic panel assay for the early-stage diagnosis of lung cancer, as well as glioblastoma (GBM), breast cancer, and head and neck cancer. It is also developing liquid biopsy tests for various cancer types, including glioblastoma, gastrointestinal, prostate, head, neck cancers. The company was incorporated in 2014 and is headquartered in Richmond, Canada.
Q&A For Biomark Diagnostics Stock
What is a current BMKDF stock price?
Biomark Diagnostics BMKDF stock price today per share is 0.39 USD.
How to purchase Biomark Diagnostics stock?
You can buy BMKDF shares on the OTC Markets OTCQB exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Biomark Diagnostics?
The stock symbol or ticker of Biomark Diagnostics is BMKDF.
Which industry does the Biomark Diagnostics company belong to?
The Biomark Diagnostics industry is Diagnostics & Research.
How many shares does Biomark Diagnostics have in circulation?
The max supply of Biomark Diagnostics shares is 105.09M.
What is Biomark Diagnostics Price to Earnings Ratio (PE Ratio)?
Biomark Diagnostics PE Ratio is now.
What was Biomark Diagnostics earnings per share over the trailing 12 months (TTM)?
Biomark Diagnostics EPS is -0.01 USD over the trailing 12 months.
Which sector does the Biomark Diagnostics company belong to?
The Biomark Diagnostics sector is Healthcare.